MedPath

Pupillary Reflex Measurement to Guide Intraoperative Analgesia During Laparoscopic Surgery

Not Applicable
Completed
Conditions
Scheduled Laparoscopic Surgery
Interventions
Device: Pupillometry guided analgesia (PP)
Drug: Tailored remifentanil controlled infusion
Drug: Tailored antihypertensive drug administration
Registration Number
NCT02116868
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The purpose of this study is to determine whether analgesia guided by pupillary reflex during laparoscopic surgery is effective in opioid sparing (intraoperative remifentanil and postoperative morphine).This is a prospective, randomized, controlled study performed in two centers.

Detailed Description

For now, intraoperative analgesia remains hard to assess in the absence of reliable and validated analgesia monitor. The analysis of pupillary reflex is a new tool to assess analgesia during the intraoperative and postoperative period.

During laparoscopic surgery, carbon dioxide insufflation that produce pneumoperitoneum may induce hemodynamics events such as tachycardia or hypertension. These events may be misleading or confusing. Actually, these events are mainly considered as insufficient analgesia. Thus, anesthesiologists deepen analgesia and/or anesthesia by increasing concentration of anesthetics or opioids. These inappropriate actions may induce hypotension and/or bradycardia especially in elderly patients. On the contrary, insufficient analgesia may exist in hypovolemic patients or in patients with neuromuscular blocking agents.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • American Society of Anesthesiologists status 1 to 4
  • Scheduled laparoscopic surgery
  • Standardized anesthesia (TCI)
  • Social security affiliation
Exclusion Criteria
  • Age < 18 yrs old
  • Emergency
  • BMI ≥ 35 kg.m-2
  • Refusal of consent
  • History of ocular pathology
  • Intake of: metoclopramide, droperidol, opioids or substitutive therapies
  • Patient with chronic pain
  • Neurologic impairments
  • Neuropathic pain
  • Drug or alcohol abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pupillometry guided analgesia (PP)Tailored remifentanil controlled infusionAnalgesia is guided by pupillary reflex. The anesthesiologist in charge must adjust the peroperative remifentanil dose (Target controlled infusion) during surgery according to the algorithm proposed. Administration of antihypertensive drugs or vasopressors is also guided.
Pupillometry guided analgesia (PP)Pupillometry guided analgesia (PP)Analgesia is guided by pupillary reflex. The anesthesiologist in charge must adjust the peroperative remifentanil dose (Target controlled infusion) during surgery according to the algorithm proposed. Administration of antihypertensive drugs or vasopressors is also guided.
Pupillometry guided analgesia (PP)Tailored antihypertensive drug administrationAnalgesia is guided by pupillary reflex. The anesthesiologist in charge must adjust the peroperative remifentanil dose (Target controlled infusion) during surgery according to the algorithm proposed. Administration of antihypertensive drugs or vasopressors is also guided.
Primary Outcome Measures
NameTimeMethod
Peroperative Remifentanil consumptionFrom the start of anesthesia to the end of surgery (<10 hours)
Secondary Outcome Measures
NameTimeMethod
Number of hemodynamic events (hypertension, hypotension, tachycardia or bradycardia...)From the start of anesthesia to the end of surgery (<10 hours)
Use of antihypertensive agents or vasopressorsFrom the start of anesthesia to the end of surgery (<10 hours)
Volume of fluid replacementFrom the start of anesthesia to the end of surgery (<10 hours)
Pain scoresIn the immediate postoperative period (<4 hours)

Using verbal rating scale

Incidence of postoperative nausea and vomiting (PONV)In the immediate postoperative period (<4 hours)
Time from extubation between the end of surgery and PACU admissionIn the immediate postoperative period (<4 hours)
Length of stay in PACUFrom PACU admission to an ALDRETE score of 10 (< 4 hours)
Immediate postoperative morphine consumptionDuring postanesthetic care unit (PACU) stay (<4 hours)

Trial Locations

Locations (2)

Centre Hospitalier Universitaire, Brabois

🇫🇷

Nancy, Lorraine, France

Maternité Régionale Universitaire (MRU)

🇫🇷

Nancy, Lorraine, France

© Copyright 2025. All Rights Reserved by MedPath